Guía de práctica clínica sobre el manejo del paciente con rectorragia

Alonso, Pedro Luis Cano; Marzo, Mercè; Mascort, Juanjo; Hervás, Antonio; Viñas, Lluís Prat; Ferrús, José Antonio; Ferrándiz, Juan; López-Rivas, Laureano; Bonfill, Xavier; Piqué, Josep M.

doi:10.1016/s0210-5705(02)70325-7

Cited by 10 publications

(2 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The efficacy of phlebotonic therapy in HD treatment, widely studied and used in chronic vascular insufficiency, remains, among scientists and physicians, debatable [9,22]. This approach is usually indicated for low-grade HD [23,24].…”

Section: Discussionmentioning

confidence: 99%

A Prospective Study on the Efficacy of Two Different Phlebotonic Therapies as a Bridge to Surgery in Patients with Advanced Hemorrhoidal Disease

Orefice

Litta

Parello

et al. 2021

JCM

View full text Add to dashboard Cite

The aims of this study were to evaluate the efficacy of two different phlebotonic therapies, preoperatively administered in advanced hemorrhoidal disease (HD) patients with recommendation for surgery, and to assess patient satisfaction after treatment. In this prospective observational study, 100 patients were preoperatively treated either with micronized purified flavonoid fraction (group A) or sublingual nano-emulsion flavonoid (group B). HD symptoms, local inflammation signs and patients’ satisfaction were evaluated at baseline visit (T0), after 4 weeks of therapy (T1) and 8 weeks after its discontinuation (T2). In group A, a significant improvement for all HD symptoms and inflammation signs was observed after therapy (T1), followed by a reduction of efficacy in T2, except for itching and edema. In group B, therapy had a significant benefit on symptoms and local inflammation at T1, which persisted after its discontinuation for all symptoms, and edematous hemorrhoids. In both groups, the satisfaction rate was “good” in 60% of patients and patients were statistically significant more satisfied at T1 compared with T2 (p = 0.0001). No adverse events were recorded. Preoperative treatment was safe and useful to optimize patients’ clinical condition prior to surgery.

show abstract

Section: Discussionmentioning

confidence: 99%

A Prospective Study on the Efficacy of Two Different Phlebotonic Therapies as a Bridge to Surgery in Patients with Advanced Hemorrhoidal Disease

Orefice

Litta

Parello

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…Its incidence is around 1.6/1000 inhabitants; 2.4-11% of them harboring colorectal cancer (2). The number of patients that recur to primary care for rectal bleeding is 4-6/1000 inhabitants (1). Nevertheless around the 30% of the patients never consult a physician for this problem (3).…”

Section: Introductionmentioning

confidence: 99%